Governments around the world will not want a repeat of what they have gone through with covid. Now health departments will be considering how to set up more accurate systems so doctors and hospitals can screen and treat patients quickly. The new testing scrutiny worldwide proves this. Virus that have long term affects and mass infection numbers are unlikely to disappear. Once Eugenie is approved the demand for it will be incredible and it will be serving a great purpose. Biotech product commercialisation takes time but when you have it the barriers to entry are massive for competitors.
ADO Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held
